Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Pacific Biosciences (PACB) Stock Explodes 21% As SoftBank Invests $900 Million, Analysts Positive
-
The Beachbody Company and Nutrition Solutions to Become Publicly Traded Company Via Merger with Forest Road Acquisition Corp. (FRX)
-
New Study: View Smart Windows Generate 68% Higher Passenger Satisfaction at Charlotte Douglas International Airport
-
Archer To List On NYSE Through Merger With Atlas Crest Investment Corp (ACIC)
-
Archer, A Leading Urban Air Mobility Company, To List On NYSE Through Merger With Atlas Crest Investment Corp
-
Archer, A Leading Urban Air Mobility Company, To List On NYSE Through Merger With Atlas Crest Investment Corp
-
Orchard Therapeutics (ORTX) PT Raised to $17 at Cantor Fitzgerald Post OTL-203 Clinical Data
-
Companies with NDRs 2/10
-
The Beachbody Company, a Leader in Digital Fitness Streaming and Nutrition Solutions, to Become Publicly Traded Company
-
KalVista Pharmaceuticals (KALV) Announces 4.5M Share Proposed Public Offering of Common Stock
-
Volitionrx Limited (VNRX) to Offer Common Stock
-
KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock
-
McEwen Mining: Registered Direct Offering of Common Stock Completed & Closed
-
McEwen Mining: Registered Direct Offering of Common Stock Completed & Closed
-
COVA Acquisition Corp. Announces Closing of $300 Million Initial Public Offering
-
METROMILE COMPLETES BUSINESS COMBINATION, WILL BEGIN TRADING ON NASDAQ AS ‘MILE’
-
METROMILE COMPLETES BUSINESS COMBINATION, WILL BEGIN TRADING ON NASDAQ AS ‘MILE’
-
IPO for SPAC Crown PropTech Acquisitions (CPTK) Opens at $10.25
-
Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced
-
Pivotal Investment Corp. III (PICC) Prices 24M Unit at $10/Unit
-
Crown PropTech Acquisitions Announces Pricing of Upsized $240 Million Initial Public Offering
-
Pivotal Investment Corp. III Announces Pricing of Upsized $240,000,000 Initial Public Offering
-
Nanox (NNOX) Announces Secondary Offering of Ordinary Shares
-
Nanox Announces Secondary Offering of Ordinary Shares
-
Atlas Crest Investment Corp. II Announces Closing of Upsized $345 Million Initial Public Offering
-
Atlas Crest Investment Corp. II Announces Closing of Upsized $345 Million Initial Public Offering
-
Corner Growth Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing February 8, 2021
-
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab
-
The Music Acquisition Corporation Announces Closing of $230 Million Initial Public Offering
-
The Music Acquisition Corporation Announces Closing of $230 Million Initial Public Offering
-
IPO for SPAC COVA Acquisition Corp (COVA) Opens at $10.42
-
McEwen Mining Announces Fox Complex Growth Funding Secured by Registered Direct Offering
-
McEwen Mining Announces Fox Complex Growth Funding Secured by Registered Direct Offering
-
Orchard Therapeutics Plc (ORTX) Reports $150M Strategic PIPE Financing from 24.12M Share Sale at $6.22/Sh
-
Orchard Therapeutics Announces $150 Million Strategic Financing
-
Orchard Therapeutics Announces $150 Million Strategic Financing
-
COVA Acquisition Corp. (COVA) Prices 26.1M Unit Upsized IPO at $10/Unit
-
COVA Acquisition Corp. Announces Pricing of Upsized $261 Million Initial Public Offering
-
Ur-Energy Inc. Announces Closing of $15.24 Million Public Equity Offering
-
DURECT Corp (DRRX) Prices $42.5 Million Public Offering of Common Stock
-
DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock
-
I-Mab (IMAB) PT Raised to $76 at Cantor Fitzgerald
-
Atlas Crest Investment Corp. II (ACII) Prices 30M Unit Upsized IPO at $10/Unit
-
Atlas Crest Investment Corp. II Announces Pricing of Upsized $300 Million Initial Public Offering
-
Atlas Crest Investment Corp. II Announces Pricing of Upsized $300 Million Initial Public Offering
-
DURECT Corp (DRRX) to Offer Common Stock
-
DURECT Corporation Announces Proposed Offering of Common Stock
-
Cantor Fitzgerald Downgrades GW Pharma (GWPH) to Neutral, Following Acquisition
-
Humana (HUM) PT Raised to $450 at Cantor Fitzgerald

